If it works then why worry about a lawsuit?
It's not a class action about a drug that doesnn't work - I live in Europe and I don't understand why the CSVI forum people think this is such a big deal.
The reason why I write this, is because after some research, (Wikipedia) I realised that because Serono isn't a US company, Rebif wasn't licensed as fast as other treatments.
Believe if or not, your FDA is protective about its home-developed drug industry.
Rebif lagged behind and provided incentives to US doctors to prescribe it.
The morals of this are obviously suspect, but I think this sort of incentive-based marketing goes on all around the world.
This doesn't mean that Rebif doesn't work- or Avonex, or Copaxone or Betaseron or Tysabri or Campath or Novantrone. None of them work for everyone with RRMS.
In the UK, you have to 'qualify' for treatment. If you have RRMS then you can choose from the CRAB drugs, if you have relapsing progressive MS, then you'll be offered Tysabri, or if you are lucky, Campath.
My neurologist had to ask for funding. No kickbacks, no incentives.
In my opinion, this website is NOT unbiased. You have a majority of posters with strong views, many of whom do not have MS.
If, by the statistics, most people diagnosed in the US seem to have Lyme Disease, then maybe thisisms should be renamed to either thisisCCSVI or thisislymedisease.
If you don't get on with your drug, you can change. Imagine life before 2002 in the UK, when you had no access to these drugs? The iniquity was outrageous.
Bubba wrote:First of all, my doctor did not recommend anything, just gave me the list of the crab drugs and said pick one. Geee Thanks.
After some research, Idecided on Rebif, A. because it was not inter muscular, and B. because it was only three times a week versus everyday. C. From what I gathered, it slightly, very slightly seemed to be the preffered drug of the five offered. Apparently, alot of doctors seemed to think it was the more effective treatment. Now, after the recent law suit, I have to wonder.